Directory
>
Sergei Atamas
Sergei Atamas
Executive Director, Research | Kiniksa Pharmaceuticals
United States
Sergei Atamas
Summary
Sergei Atamas is an accomplished Executive Director with extensive experience in translational immunology and drug development. He has a rich background in leading research teams across various stages of the drug discovery process, particularly in immune and autoimmune diseases. Sergei's strategic leadership skills are complemented by his hands-on approach to operational management, fostering a collaborative and innovative research culture. His expertise spans a wide array of scientific disciplines, including biochemistry, cell biology, and genomics, making him a valuable asset in the life sciences sector. Sergei has held significant positions in both academia and the pharmaceutical industry, demonstrating his versatility and commitment to scientific excellence. He is particularly skilled in managing complex projects and promoting teamwork in fast-paced environments. His dedication to advancing medical research is evident in his long-standing career and contributions to the field.
Sergei Atamas
Work Experience
Executive Director, Research at
Kiniksa Pharmaceuticals
June 2023 - Present
Sr. Director, Translational Research at
Kiniksa Pharmaceuticals
November 2021 - June 2023
Co-Founder and Chief Scientific Officer at
Avanzarx Pharmaceuticals
December 2020 - May 2022
Executive Director, Research at
Corbus Pharmaceuticals
April 2019 - December 2020
Professor of Medicine and Microbiology & Immunology at
University of Maryland Pediatric Associates PA
January 1994 - March 2019
Research Health Scientist at
Department of Veterans Affairs
January 2000 - January 2019
Frequently Asked Questions about Sergei Atamas
What is Sergei Atamas email address?
Sergei Atamas's primary email address is *******@kiniksa.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sergei Atamas work for?
Sergei Atamas is a Executive Director, Research at Kiniksa Pharmaceuticals, a company specializing in Commercial physical research.
How can I directly contact Sergei Atamas?
To contact Sergei Atamas directly, you can use the email address *******@kiniksa.com. Complete contact information is available upon registration with Muraena.
Who is Sergei Atamas?
Sergei Atamas is an accomplished Executive Director with extensive experience in translational immunology and drug development. He has a rich background in leading research teams across various stages of the drug discovery process, particularly in immune and autoimmune diseases. Sergei's strategic leadership skills are complemented by his hands-on approach to operational management, fostering a collaborative and innovative research culture. His expertise spans a wide array of scientific disciplines, including biochemistry, cell biology, and genomics, making him a valuable asset in the life sciences sector. Sergei has held significant positions in both academia and the pharmaceutical industry, demonstrating his versatility and commitment to scientific excellence. He is particularly skilled in managing complex projects and promoting teamwork in fast-paced environments. His dedication to advancing medical research is evident in his long-standing career and contributions to the field.
Sergei`s contact details
*******@kiniksa.com
*******@umaryland.edu
*******@umm.edu
Colleagues
Vice President Medical Affairs
SVP, Chief Commercial Officer
VP, Clinical Research & Development
Vice President, Clinical Research & Development
Vice President, Clinical Operations
Group Vice President, Commercial Operations and Portfolio Insights
Vice President Information Technology
Vice President, Financial Planning & Analysis
VP, Head of Quality
Executive Director, Drug Product Development and Manufacturing